Top Story

Financial incentives may influence oncologists’ practice patterns

January 15, 2019
Meeting News

Pembrolizumab reduces mortality risk in advanced PD-L1-positive esophageal cancer

January 15, 2019
Pembrolizumab significantly improved OS compared with chemotherapy as second-line treatment for patients with advanced or metastatic esophageal or esophagogastric…

Task force: Medications to reduce breast cancer risk ‘are not for everyone’

January 15, 2019
Medications intended to reduce risk for breast cancer should be offered to women with an elevated risk for the disease but a low risk for adverse events associated with…
FDA News

FDA approves Cabometyx for treatment-experienced patients with HCC

January 15, 2019
Exelixis has announced it has received FDA approval for Cabometyx to treat patients with hepatocellular carcinoma who previously underwent treatment with Nexavar…
In the Journals Plus

Treatment at academic centers yields survival benefit in metastatic NSCLC

January 15, 2019
Patients with metastatic non-small cell lung cancer who received treatment at academic…
More Headlines »

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

This activity is supported by an educational grant from Kyowa Kirin, Inc.

Cutaneous T-cell lymphoma (CTCL) is a rare and heterogeneous type of T-cell lymphoma that is often challenging to…
More »
Meeting News

VIDEO: ASGE works toward movement on MIPS, MACRA

August 17, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition


Ace the Case: A 55-Year-Old Woman With an Oddly-Shaped, Raised Pigmented Lesion on Right Thigh

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case-based approach in a 55-year-old woman to discuss the diagnosis and…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next